Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reversible cardiomyopathy associated with sunitinib and sorafenib.

Reversible cardiomyopathy associated with sunitinib and sorafenib. N Engl J Med. 2011 Oct 27; 365(17):1649-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.